ABSTRACT A review of 157 consecutive biopsies ofdonor endomyocardium in patients with heterotopic heart transplants is reported. The technique ofpercutaneous transvenous endomyocardial biopsy after this operation is described; manipulation of the catheter and bioptome into the junction of the donor superior vena cava and right atrium can be difficult when this anastomotic junction is small, as a result either ofoperative surgical technique or ofsubsequent contraction. The complication rate was 40
The diagnosis of rejection in transplanted hearts, whether orthotopic or heterotopic, may be difficult and cannot await the appearance ofclinical signs ifsevere immunological damage is to be avoided. Electrocardiographic changes may indicate rejection; a decrease in QRS voltage of20% or more has long been held to suggest rejection,' 2 although there are many other factors which may influence the QRS voltage.3
Percutaneous transvenous or transarterial biopsy of rightandleftventricleswithaspeciallydesignedforceps, to provide fragments of endomyocardium for histological examination, was first described by Sakakibara and Konno in 19624 and 10 years later was introduced as a clinical tool in heart transplantation by Caves and his colleagues.5 Biopsy remains the single most useful diagnostic aid in assessing rejection in the donor heart, being superior to electrocardiography67; since 1976 it has been used increasingly at Groote Schuur Hospital in the management of patients undergoing heart transplantation.
We have reviewed 157 consecutive biopsies ofdonor hearts performed from January 1979 to April 1981. In this report we emphasise the technical problems of biopsy in patients with heterotopic heart transplants, the complications of the procedure in our hands and the clinical value of the histopathological information obtained.
Methods

THE PATIENTS
Since 1979 it has been our policy to perform biopsies on donor hearts about once a week during the first month after transplantation, with decreasing frequency during subsequent months. Biopsy is also performed whenever a rejection episode is suspected, and to assess the efficacy of a course ofanti-rejection treatment 
HISTOLOGY
The endomyocardial samples usually comprise one to four fragments, each 1-2 mm in diameter, submitted in 5% glutaraldehyde to facilitate subsequent ultrastructural examination of one of the fragments. Two fragments are subsequently fixed in 5%buffered formaldehyde and processed in the routine manner. Paraffinembedded sections are then stained by the haematoxylin-eosin, elastic van Gieson, and UnnaPappenheim methods.
Assessment ofrejection is based on light microscopy; we have attempted to grade the histopathological changes seen, the aim being to give the clinician a guide to the severity of rejection and to the efficacy of antirejection treatment. The reproducibility of histological interpretation is enhanced since we always use the same criteria to assess the biopsy specimens and give them scores, rather than basing the diagnosis of rejection on an overall impression of the specimens.
Five histological criteria are independently assessed: interstitial oedema, interstitial mononuclear cell infiltration, cytoplasmic pyroninophilia ofthe mononuclear cells (as assessed on Unna-Pappenheim staining), myofibre degeneration, and blood vessel alterations. Myofibre alterations include oedema, loss of sharp contour, indistinct cross-striations, myocytolysis, fragmentation, and coagulative necrosis. Blood vessel alterations include intimal cell proliferation or necrosis, medial cell loss, and mononuclear infiltration of the vessel wall.
The presence or absence of each of these five histological criteria is scored from 0 to 3 as follows: 0-absent or normal, 1-mild change, 2-moderate change, 3-severe change. The sum ofthese scores from the biopsy specimen showing the most severe changes ofrejection is the final score and theoretically this may be as high as 15, though in clinical specimens scores above 7 are rare (in the experimental animal, when acute rejection is allowed to progress to a conclusion, a score of 15 is not uncommon). In our experience a final score ofO implies that no rejection is occurring, 0.5-2 denotes mild acute rejection, 2.5-4 moderate acute rejection, and more than 4 severe acute rejection.
Results
Persistent difficulty was encountered in four patients, three immediately after operation and one three months after surgery. This was related to stenosis of the anastomosis, resulting from either operative technique or subsequent shrinkage during healing, or both. In three cases passage ofthe catheter from the right orleft femoral vein overcame this problem. In one of these patients, however, the anastomosis contracted over nine months to a size where it became impossible to enter the donor right atrium at all. In such patients percutaneous trans- The scores given to the 157 biopsy specimens forming the basis ofthis paper are shown in table 1. In addition, fibrosis, suggesting previous myofibre damage from acute or chronic rejection, was seen in 42 samples.
Histopathological assessment was ofclinical value in 96% ofthe cases in which the biopsy was adequate, but was interpreted incorrectlyin clinical terms on fouroccasions and was misleading on two. The assessment was of value in either confirming or excluding the presence of suspected acute rejection or in showing its presence when it had not been suspected-(table 2). The histopathological response to a more intensive course of immunosuppressive treatment could also be assessed as either indicating or ruling out the need for continued high-dose treatment; excessive treatment could thus be avoided.
Itis difficulttobe certain whetherthere have beenany "false-positive" reports, though this would seem unlikely as a previous study from ourinstitution showed that the histological changes ofrejection are equally distributed between the left and right ventricles, including the interventricular septum.8 On occasion, within the 18-24 hours required to process and stain the biopsy tissue, electrocardiographic evidence of rejection has become manifest, supporting a positive biopsy result. In our experience the ECG voltage may be unchanged even with severe acute rejection and we have seen one patient with a biopsy score of7.0 whose QRS voltage did not fall until the day after the biopsy. If a rejection episode is strongly suspected -for example, on clinical or electrocardiographic groundsbut is not confirmed by biopsy, the biopsy is usually repeated. In view ofthe subsequent clinical course and information from serial biopsies, we believe that on six occasions the information obtained from the biopsy specimens ortheirinterpretationwas orcouldhavebeen misleading. The two causes oferror have been an inadequate biopsy specimen on one occasion (on which we can see in retrospectthat no report should have been proferred) and observer error on the part ofthe pathologist on the second, too low a score being given in both cases. On the four occasions on which interpretation may have been at fault the circumstances were similar and appear to indicate a need to remain suspicious of a "negative" histopathological report when there are strong electrocardiographic orother indications that rejection is occurring or that the donor heart function is deteriorating appreciably. Low scores were reported on four occasions (in two patients) when rejection was clinically suspected, on three occasions associated with evidence of impaired donor heart function. Both patients subsequently suffered irreversible loss ofgraft function. In each patient persistence or repeated episodes of relatively low-grade acute rejection or chronic rejection (immunologically induced accelerated coronary atherosclerosis), or both, over several weeks resulted in considerable replacement fibrosis. Although patchy fibrosis was observed in the biopsy specimen and reported, clinical attention was concentrated on the histological features of acute rejection and, as these were relatively minor, no extra treatment was administered. When chronic rejection increases there is little extra treatment that can be offered to the patient, but when the fibrosis is a result ofrepeated episodes oflow-grade acute rejection then failure to increase treatment may lead to early graft failure. We describe one such case.
One year after transplantation, with only one moderate rejection episode during that period, the patient developed an appreciable and rapid fall in ECG voltage; at biopsy a score of1.0 was obtained, and he was discharged from hospital and allowed to go on holiday. He returned a month later with graft failure, which proved irreversible even with massive and prolonged anti-rejection treatment. Even at this time, however, the features of acute rejection on histological examination were only moderate (score 3-5), though significant fibrosis was noted. It would seem likely that relatively lowgrade, untreated acute rejection persisting over one month, possibly combined with chronic rejection, led to severe myocardial damage and replacement fibrosis. The initial fall in ECG voltage, despite a histopathological report suggesting only mild acute rejection, should have been viewed more suspiciously and the patient followed up at an early date. rather than low-grade acute rejection was the main process no form oftreatment is likely to have been successful. This patient has subsequently undergone excision ofthe donor heart and retransplantation. Changes ofchronic rejection are not always evident in the endomyocardium as the impairment ofmyocardial blood supply thatresults from immunologically-induced coronary vessel wall damage may spare the endomyocardium (fig 2) , since this receives an adequate alternative blood supply direct from the ventricular cavity. This phenomenon may in part explain a histopathological report that does not reflect the true situation. Discussion Endomyocardial biopsy in heterotopic cardiac transplantation is a relatively safe invasive procedurewith few important technical problems. About 94% of biopsy procedures provide tissue samples adequate for meaningful histopathological assessment.
Cefamandole given intravenously for 24 hours to cover the biopsy procedure was effective as prophylaxis against infection, with two possible exceptions-both of which were associated with circulatory access via the femoral vessels. Percutaneous transvenous endomyocardial biopsyperformed bythe subclavian route has not been associated with any infective complication in our hands.
Potential complications of this technique, not encountered in this series, include pulmonary embolism (or systemic embolism in the case of left ventricular biopsy) from dislodgement of mural stasis thrombus, which may result from decreased myocardial contractions due to rejection, and perforation of the right ventricular myocardium. (The latter has been a complication of one subsequent biopsy, 550 ml of blood being Endomyocardial biopsy remains, however, the single most useful indicator ofgraft rejection. The information it provides can be obtained with a relatively low complication rate (4% in the present series) and with little discomfort to the patient. One patient, however, may have died from infection introduced at biopsy, and therefore the search for a non-invasive method of confirming, or preferably predicting, rejection continues. 
